Safe S.A. specializes in the design, manufacture and marketing of medical devices for spine surgery. The company offers implants and instruments in the range of SteriSpine (the first spinal arthrodesis system that is for single use and is sterile and totally traceable). The group's activity is organized around 2 areas: - direct and indirect sales of medical devices (Safe Orthopaedics): business carried out in France, Germany, the United Kingdom, the United States and South America; - subcontracted manufacturing services for orthopedic medical devices (Safe Medical).

Employees

Sector

Medical Equipment, Supplies & Distribution

More about the company

Market Cap	58.38K 66.78K 53.65K 50.01K 94.86K 6.36M 96.29K 644K 250K 3.13M 251K 245K 10.77M	P/E 2024	-77.6x	P/E 2025	-87.5x
Enterprise Value	13.17M 15.07M 12.1M 11.28M 21.4M 1.43B 21.72M 145M 56.49M 705M 56.55M 55.34M 2.43B	EV / Sales 2024	2.39x	EV / Sales 2025	2.47x
Free-Float	95.95%	Yield 2024 *	-	Yield 2025	-

06-30	Safe Group sharply improves its full-year results
06-28	Safe Orthopaedics SA Reports Earnings Results for the Full Year Ended December 31, 2025	CI
05-28	Safe And ABL Alpstein Sign Exclusive Distribution Agreement For SteriSpine Range In Peru	CI
05-28	Safe Group enters Peru with exclusive distribution agreement
03-16	Changes to the SAFE Board of Directors
12-17	Safe Orthopaedics Signs Exclusive Distribution Agreement for Spanish Market	MT
12-17	Safe Group Signs Strategic Distribution Agreement in Spain with Vortrom Biologics	CI
11-30	Safe Orthopaedics SA Reports Earnings Results for the Full Year Ended December 31, 2024	CI
25-07-28	Alert wrongly tagged to Safe SA withdrawn	RE
24-12-27	Safe Orthopaedics SA Reports Earnings Results for the Half Year Ended June 30, 2024	CI
24-09-09	The market burns its idols
24-02-05	Safe: wins its appeal against Neo Medical
23-12-28	Safe: audit initiated for a turnaround plan

12-22	SAFE, SPONSOR OF THE 12TH MAMMI INTERNATIONAL CONFERENCE IN ITALY	GL
12-17	SAFE SIGNS A STRATEGIC DISTRIBUTION AGREEMENT IN SPAIN WITH VORTROM BIOLOGICS	GL
12-17	SAFE SIGNS A STRATEGIC DISTRIBUTION AGREEMENT IN SPAIN WITH VORTROM BIOLOGICS	AQ
24-09-09	New bond financing agreement in a minimum amount of €3 million in anticipation of validation of the continuation plan	GL
23-11-24	Safe group announces the convocation of the Annual General Meeting of Shareholders to be held on December 15th 2023 and provides an update on the situation	AQ

06-30	Safe Group améliore nettement ses résultats annuels
05-28	Safe Group s'implante au Pérou avec un accord de distribution exclusif
04-28	Safe S A : Report de la publication des résultats annuels 2025 de SAFE Group
03-31	SAFE - Forte dynamique de développement au Venezuela
03-16	Evolutions au sein du Conseil d'Administration de SAFE

Manager	Title	Age	Since
Nicolas Papillon CEO	Chief Executive Officer	46	-
Thomas Droulout CTO	Chief Tech/Sci/R&D Officer	50	2010-02-14
François-Henri Reynaud DFI	Director of Finance/CFO	-	2017-11-08

Safe Orthopaedics SA Stock OTC Markets

Stocks

SAFO.F

FR0013467123

Medical Equipment, Supplies & Distribution

Valuation: Safe Orthopaedics SA

Latest news : Safe Orthopaedics SA

Press Releases: Safe Orthopaedics SA

News in other languages: Safe Orthopaedics SA

Managers and Directors: Safe Orthopaedics SA

Medical Devices & Implants

Financials

Company Profile

Director	Title	Age	Since
Thomas Droulout BRD	Director/Board Member	50	-
François-Henri Reynaud BRD	Director/Board Member	-	2019-11-25
Ismaël Nujurally BRD	Director/Board Member	69	2019-11-25

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
SAFE ORTHOPAEDICS SA	-.--%	-.--%	-	-	66.78K
STRYKER CORPORATION	+4.20%	-1.85%	-17.39%	+9.58%	125B
SMITH & NEPHEW PLC	+0.04%	-1.01%	+1.39%	-6.08%	12.77B
GLAUKOS CORPORATION	+7.83%	+2.71%	+43.32%	+112.86%	8.71B
IMEIK TECHNOLOGY DEVELOPMENT CO.,LTD.	+2.29%	+7.17%	-46.92%	-72.29%	4.07B
DOUBLE MEDICAL TECHNOLOGY INC.	+4.16%	+8.39%	+25.37%	+43.89%	2.73B
BEIJING BALANCE MEDICAL TECHNOLOGY CO.,LTD.	+2.53%	+23.07%	-7.66%	-13.04%	1.89B
SHANGHAI MICROPORT ENDOVASCULAR MEDTECH CO., LTD.	+3.55%	+8.85%	-0.99%	-23.29%	1.67B
L&C BIO CO.,LTD	-5.25%	-5.89%	+179.33%	+133.76%	1.46B
Average	+2.15%	+1.23%	+22.06%	+23.17%	19.81B
Weighted average by Cap.	+3.90%	+2.90%	-10.46%	+13.01%

	2024	2025
Net sales	5.04M 5.77M 4.63M 4.32M 8.19M 549M 8.31M 55.62M 21.62M 270M 21.64M 21.18M 930M	5.36M 6.14M 4.93M 4.59M 8.72M 584M 8.85M 59.18M 23.01M 287M 23.03M 22.54M 990M
Net income	-1.93B -2.21B -1.77B -1.65B -3.13B -210B -3.18B -21.29B -8.27B -103B -8.28B -8.11B -356B	-4.67M -5.35M -4.3M -4M -7.59M -509M -7.71M -51.57M -20.05M -250M -20.07M -19.64M -862M
Net Debt	11.47M 13.12M 10.54M 9.83M 18.64M 1.25B 18.92M 127M 49.2M 614M 49.25M 48.2M 2.12B	13.11M 15M 12.05M 11.23M 21.3M 1.43B 21.63M 145M 56.24M 702M 56.3M 55.09M 2.42B